Compared with the general public, people in prison in the EU/EEA have a higher burden of communicable diseases such as human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis, gonorrhoea, chlamydia and tuberculosis (TB). Increased disease prevalence in this population is...

A higher prevalence of communicable diseases among people in prison compared with the general public is recognised as a public health issue as well as a major concern for the people affected, as the majority of incarcerated people return to their communities. Active case finding is a key...

Greece has experienced a fairly stable, low-level HIV epidemic for a number of years. Men who have sex with men have been the most affected population. Since the beginning of 2011, Greece has been facing a significant outbreak of HIV among people who inject drugs in Athens. In the first four...

The aim of the literature review presented in this report was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 'Guidance on the prevention and control of infectious diseases among people who inject drugs'. The evidence presented here focuses on the...

Since the emergence of the HIV epidemic among people who inject drugs in the mid-1980s, many European countries have achieved substantial progress in implementing evidence-based measures to prevent and control infectious diseases among this group. In the 1990s, EU countries started to develop...

This report presents the results of two literature reviews. The aim of the reviews was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 publication 'Guidance on the prevention and control of infectious diseases among people who inject drugs'. The evidence...

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs. The guidance identifies seven key interventions which, in...

Since the emergence of the HIV epidemic among people who inject drugs in the mid-1980s, many European countries have achieved substantial progress in implementing evidence-based measures to prevent and control infectious diseases among this group. In the 1990s, EU countries started to develop...

Compared with the general public, people in prison in the EU/EEA have a higher burden of communicable diseases such as human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis, gonorrhoea, chlamydia and tuberculosis (TB). Increased disease prevalence in this population is...

This guidance is based on a series of systematic reviews of the scientific literature. Research findings were assessed using evidence-based medicine principles, adapted within a public health framework and combined with advice from a panel of European prison experts. The conclusions listed are...